Altogether, this suggests that selective inhibition of HDAC1-3 could alter the balance between pro- and anti-inflammatory gene expression via regulation of NF-κB acetylation, thereby suppressing inflammation in COPD. This evidence concerns the gene HDAC1 and chronic obstructive pulmonary disease.